Ryotaro Morinaga

765 citations
27 papers · 496 indexed · h-index 12
Topics
Lung Cancer Treatments and Mutations (12 papers)Lung Cancer Research Studies (8 papers)Colorectal Cancer Treatments and Studies (5 papers)
Partner nations
JapanGermanySwitzerland

In The Last Decade

Ryotaro Morinaga

27 papers receiving 491 citations

Peers

Ryotaro Morinaga
Comparison fields: 5 of 61
  • Pulmonary and Respiratory Medicine 338
  • Oncology 318
  • Molecular Biology 147
  • Cancer Research 82
  • Epidemiology 52
Replace Yasuhiro Arakawa with:
Yasuhiro Arakawa Japan
Ren-bao Yang China
Yoshinobu Namba Japan
Zhefeng Liu China
Aliyah Pabani Canada
Karin Rita Tamas Switzerland
Avril Mf France
Abhishek Tripathi United States
Alice Hervieu France
Ryotaro Morinaga relative to Yasuhiro Arakawa Japan Yasuhiro Arakawa's profile →
Citations per field
00.5×3.9×
Yasuhiro Arakawa · 1×
Citations per year

Countries citing papers authored by Ryotaro Morinaga

Since Specialization
Citations

This map shows the geographic impact of Ryotaro Morinaga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryotaro Morinaga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryotaro Morinaga more than expected).

Fields of papers citing papers by Ryotaro Morinaga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryotaro Morinaga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryotaro Morinaga. The network helps show where Ryotaro Morinaga may publish in the future.

Co-authorship network of co-authors of Ryotaro Morinaga

This figure shows the co-authorship network connecting the top 25 collaborators of Ryotaro Morinaga. A scholar is included among the top collaborators of Ryotaro Morinaga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryotaro Morinaga. Ryotaro Morinaga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 10
3 9
4 1
5 16
6 22
7 27
8 2
9 14
10 79
11 7
12 39
13
[Case of toxocariasis showing migratory nodular shadows with halos].
4
14 31
15 13
16
[Chronic hypersensitivity pneumonitis induced by Shiitake mushroom cultivation: case report and review of literature].
5
17
[Pulmonary metastasis of fibrosarcomatous variant of dermatofibrosarcoma protuberans: case report and review of literature].
2
18
[A case of diaphragmatic paralysis caused by herpes zoster after anticancer chemotherapy].
4
19 96
20 4

About Ryotaro Morinaga

Ryotaro Morinaga is a scholar working on Oncology, Applied Microbiology and Biotechnology and Pulmonary and Respiratory Medicine, having authored 27 papers that have together received 496 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (12 papers), Lung Cancer Research Studies (8 papers) and Colorectal Cancer Treatments and Studies (5 papers). The work is most often cited by research in Oncology (318 citations), Pulmonary and Respiratory Medicine (338 citations) and Cancer Research (82 citations). Ryotaro Morinaga has collaborated with scholars based in Japan, Germany and Switzerland. Frequent co-authors include Isamu Okamoto, Kazuhiko Nakagawa, Kazuto Nishio, Masahiro Fukuoka, Masaru Sekijima, Kazuyuki Furuta, Kensaku Dote, Takao Satou, Hiroyasu Kaneda and Masaki Miyazaki. Their work appears in journals such as Journal of Clinical Oncology, Oncotarget and Molecular Cancer Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026